Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIUMPH: Mirabegron vs Tolterodine in Elderly Women with Urgency Urinary Incontinence
NCT02436889Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in urge incontinence, sponsored by University of California, San Francisco. Started Feb 2016; status: completed.
02
Drugs
mirabegron
03
Conditions
urge incontinence
Beyond the preview
Go deeper on NCT02436889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02436889.